← Back to Sun Pharma Advanced Research Company Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

SPARCPharmaceuticals

Sun Pharma Advanced Research Company Ltd — Financial Ratios & Key Metrics

₹114.89

-8.03%

P/E RatioN/AxIndustry: 31.77x

ROEN/AReturn on equity

ROCE-297.83%Return on capital

Debt/EquityN/ADebt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹4.36K (Cr)

Sales Growth 5Y

-1.35%

Profit Growth 5Y

-1.73%

EPS Growth 5Y

2.39%

OPM 5Y Avg

-163.17%

📉

Price Returns

1 Month

-0.74%

3 Months

-6.50%

6 Months

-14.44%

1 Year

-38.01%

52W Low

₹108

Current

₹115

52W High

₹204

7% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹128

▼ Price below SMA 50 — Bearish

SMA 200

₹139

▼ Long-term downtrend

Volume Signal

228% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Sun Pharma Advanced Research Company Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.